首页> 外文期刊>International Journal of Nanomedicine >Comparative analysis between four model nanoformulations of amphotericin B-chitosan, amphotericin B-dendrimer, betulinic acid-chitosan and betulinic acid-dendrimer for treatment of Leishmania major : real-time PCR assay plus
【24h】

Comparative analysis between four model nanoformulations of amphotericin B-chitosan, amphotericin B-dendrimer, betulinic acid-chitosan and betulinic acid-dendrimer for treatment of Leishmania major : real-time PCR assay plus

机译:两性霉素B-壳聚糖,两性霉素B-树状大分子,桦木酸-壳聚糖和桦木酸-树状大分子在利什曼原虫病治疗中的四种模型纳米制剂的比较分析:实时PCR分析加

获取原文
           

摘要

Background: Amphotericin B (Amp) and Betulinic acid (BA) as antileishmanial agents have negligible water solubility and high toxicity. To solve these problems, for the first time, chitosan nanoparticles and Anionic Linear Globular Dendrimer (D) were synthesized for the treatment of Leishmania major ( L. major) . Method: Chitosan and dendrimer nanoparticles were synthesized, and Amp and BA were loaded into the nanoparticles. The particles were then characterized using various methods and their efficacy was evaluated in vitro and in vivo environments (parasite burden was confirmed using pathological studies and real-time PCR methods). Result: The results of docking showed that Amp and BA can be loaded into chitosan and dendrimer nanoparticles. The results of physically drug loading efficiency for AK (Amphotericin B-chitosan), BK (Betulinic acid-chitosan), AD (Amphotericin B-Dendrimer) and BD (Betulinic acid- Dendrimer) were 90, 93, 84 and 96 percent, respectively. The characterization results indicated that the drugs were loaded into nanoparticles physically. Moreover, the increased solubility rate for AD=478, BD=790, AK=80 and BK=300 folds. Furthermore, the results of the drug delivery system showed the slow controlled drug release pattern with cellular uptake of more than 90%. The treatment results showed a 100 percent decrease of toxicity for the all nanodrugs was observed in vivo and in vitro environments. Moreover, AK10 and BK20?mg/kg reduced parasite burden by 83 percent ( P 0.001), while AD50 and BD40?mg/kg reduced it to a lesser extent compared to glucantime. Conclusion: All the synthesized nanodrugs were completely succeeded by 100% to recovery the L. major induced pathological effects in the infected footpad. Also, the results of present study were confirmed with real-time PCR and the results showed that AK and BK were succeeded in a large extent to the treatment of L. major infection ( P 0.001), therefore AK and BK could be considered as proper alternatives of choices drugs.
机译:背景:两性霉素B(Amp)和贝特林酸(BA)作为抗霉菌剂,其水溶性可忽略不计,且毒性很高。为了解决这些问题,首次合成了壳聚糖纳米颗粒和阴离子线性球状树枝状大分子(D)用于治疗大利什曼原虫(L.major)。方法:合成壳聚糖和树枝状聚合物纳米粒子,并将Amp和BA装入纳米粒子中。然后使用各种方法对颗粒进行表征,并在体外和体内环境中评估其功效(使用病理研究和实时PCR方法确认了寄生虫负担)。结果:对接结果表明,Amp和BA可以负载到壳聚糖和树枝状聚合物纳米颗粒中。 AK(两性霉素B-壳聚糖),BK(白蛋白酸-壳聚糖),AD(两性霉素B-Dendrimer)和BD(白蛋白酸-树枝状聚合物)的物理药物装载效率结果分别为90%,93、84和96% 。表征结果表明药物被物理负载到纳米颗粒中。此外,对于AD = 478,BD = 790,AK = 80和BK = 300倍,增加的溶解度。此外,药物递送系统的结果显示出缓慢受控的药物释放模式,细胞吸收超过90%。治疗结果表明,在体内和体外环境中,所有纳米药物的毒性均降低了100%。此外,与葡聚糖时间相比,AK10和BK20?mg / kg降低了83%的寄生虫负担(P <0.001),而AD50和BD40?mg / kg降低了较少的程度。结论:所有合成的纳米药物均能以100%的成功完全恢复被感染足垫中L.主要诱导的病理作用。此外,本研究的结果已通过实时PCR证实,结果表明,AK和BK在很大程度上治疗了大肠埃希菌感染(P <0.001),因此可以将AK和BK视为选择药物的适当替代品。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号